Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V WYNN

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Reproductive Medicine|March 1, 1991
Coronary heart disease risk markers in users of low-dose oral contraceptivesI F Godsland, D Crook, V Wynn
Diabetologia|May 1, 1987
Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamicsN M Shennan, I F Godsland, V Wynn
Lancet (London, England)|March 2, 1985
Method for estimating rate of fat loss during treatment of obesity by calorie restrictionV Wynn, R R Abraham, J W Densem
Clinical Science (London, England : 1979)|December 1, 1986
Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol)I F Godsland, N M Shennan, V Wynn
Electroencephalography and Clinical Neurophysiology|March 1, 1986
Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathyR R Abraham, R M Abraham, V Wynn
Memory & Cognition|July 1, 1994
Counting on working memory in arithmetic problem solvingR H Logie, K J Gilhooly, V Wynn
Advances in Experimental Medicine and Biology|January 1, 1984
A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathyR R Abraham, R M Abraham, V Wynn
Proceedings of the Royal Society of Medicine|January 1, 1976
Lipokinetic studies with gemfibrozil (CI-719)A H Kissebah, P A Adams, V Wynn
Journal of Endocrinological Investigation|June 1, 1987
The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parametersJ H Parr, M Seed, I Godsland, et al.
Contraception|September 1, 1995
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular diseaseI F Godsland, D Crook, M Devenport, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Reproductive Medicine|March 1, 1991
Coronary heart disease risk markers in users of low-dose oral contraceptivesI F Godsland, D Crook, V Wynn
Diabetologia|May 1, 1987
Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamicsN M Shennan, I F Godsland, V Wynn
Lancet (London, England)|March 2, 1985
Method for estimating rate of fat loss during treatment of obesity by calorie restrictionV Wynn, R R Abraham, J W Densem
Clinical Science (London, England : 1979)|December 1, 1986
Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol)I F Godsland, N M Shennan, V Wynn
Electroencephalography and Clinical Neurophysiology|March 1, 1986
Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathyR R Abraham, R M Abraham, V Wynn
Memory & Cognition|July 1, 1994
Counting on working memory in arithmetic problem solvingR H Logie, K J Gilhooly, V Wynn
Advances in Experimental Medicine and Biology|January 1, 1984
A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathyR R Abraham, R M Abraham, V Wynn
Proceedings of the Royal Society of Medicine|January 1, 1976
Lipokinetic studies with gemfibrozil (CI-719)A H Kissebah, P A Adams, V Wynn
Journal of Endocrinological Investigation|June 1, 1987
The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parametersJ H Parr, M Seed, I Godsland, et al.
Contraception|September 1, 1995
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular diseaseI F Godsland, D Crook, M Devenport, et al.
Pageof 8